Be a part of 16^th World Nephrology Conference

Session 01: Artificial Intelligence and Machine Learning
Artificial Intelligence and Machine Learning revolutionize nephrology, aiding in diagnosis, treatment, and patient management. They analyze vast datasets for early detection of kidney diseases, predict progression, and personalize therapies. Smart algorithms enhance dialysis efficiency and streamline transplant matching. These technologies promise to transform kidney care, improving patient outcomes.
AI conferences | Machine learning events | Robotics summits | Nephrology conferences
Session 02: Advancements in Dialysis Technology
Recent dialysis tech innovations, like portable devices and hemodiafiltration, improve kidney treatment. Bioartificial kidneys and nanotech offer hope for the future. The global home dialysis market, valued at $86.9 billion in 2023, is expected to grow to $105.1 billion by 2027, with a 6.4% CAGR.
Kidney conferences | Kidney summits | Nephrology conferences | Kidney Treatment and care events
Session 03: Precision Medicine in Nephrology
Precision medicine in kidney disease tailors treatments based on genetic, environmental, and lifestyle factors. It identifies genetic markers, biomarkers, and risk profiles for personalized care. This approach enables targeted therapies, and early intervention, and empowers patients to manage their kidney health for better outcomes.
Nephrology conference | Nephrology summit | Kidney disease conferences | Renal care meetings
Session 04: Biomarkers for Kidney Disease
Biomarkers are vital for diagnosis, progress tracking, and treatment evaluation in kidney disease. Notably, albumin-to-creatinine ratio and kidney injury molecule-1 offer crucial insights. Genetic markers aid risk assessment, enabling precision medicine. The Renal Biomarkers Market is set to grow from USD 1.24 billion in 2023 to USD 1.77 billion by 2028, with a CAGR of 7.29%.
Biomarkers conferences | Kidney disease summits | Kidney conferences | Nephrology summits
Session 05: Immunotherapy in Glomerular Diseases
Immunotherapy in glomerular diseases targets immune responses causing kidney damage. Utilizing agents like monoclonal antibodies and corticosteroids, it shows promise in treating conditions like lupus nephritis and membranous nephropathy. The Global Glomerular Disease Therapeutics Market, valued at USD 12,590.4 million in 2023, is projected to reach USD 18,601.7 million by 2029, with an expected CAGR of 5%.
Immunotherapy conferences | Immunotherapy meetings | Glomerular diseases conferences | Nephrology conferences
Session 06: Exosome-based Therapies
Exosome-based nephrology therapies hold the potential for kidney repair, inflammation reduction, and fibrosis treatment. Derived from cells like MSCs, they deliver bioactive molecules for tissue healing and immune regulation. Promising for AKI, glomerulonephritis, and CKD, the global market for exosome products is expected to reach $2.9 billion by 2030, with a 29.4% CAGR from 2021 to 2030.
Kidney conferences | Kidney summits | Nephrology conferences | Kidney Treatment and care events
Session 07: Advances in Renal Replacement Therapy
Innovations in renal replacement therapies, including hemodialysis, peritoneal dialysis, and kidney transplantation, are significantly improving patient quality of life and survival rates. Recent strides in kidney transplantation encompass expanded donor options, potent immunosuppressive drugs, and refined surgical methods, personalized matching, and advanced organ preservation techniques. This progress contributes to improved outcomes. The global kidney transplant market is forecasted to increase from $5.49 billion in 2023 to $5.80 billion in 2025, with a 5.7% CAGR.
Renal transplantation events | Kidney treatment & care summit | Nephrology summit | Nephrology meetings
Session 08: Telemedicine in Nephrology
Telemedicine in nephrology employs technology for remote kidney-related care, enabling virtual consultations and monitoring of vital signs, especially vital for chronic conditions. It enhances accessibility, is crucial for rural or underserved areas, and gained prominence during the COVID-19 pandemic. The global telemedicine market is projected to reach $131.75 billion in 2025 with a 27.8% CAGR.
Telemedicine conferences | Digital health summits | Nephrology conferences | Kidney conferences
Session 09: Nutritional Management in Kidney Disease
Nutritional management in kidney disease involves customizing diets, regulating protein, sodium, potassium, and phosphorus intake, and monitoring fluid balance. Dialysis may require specific dietary adjustments. Registered dietitians play a crucial role in crafting personalized nutrition plans. The global chronic kidney disease treatment market was valued at $32 billion in 2022, projected to reach $47.9 billion by 2032, with a 4% CAGR from 2023 to 2032.
Kidney disease conferences | Nutrition care summits | Kidney disease events | Nephrology meetings
Session 10: Interventional Nephrology
Interventional nephrology employs minimally invasive procedures for diagnosing and treating kidney conditions, like catheter insertion, kidney biopsies, and dialysis access management. It significantly enhances patient outcomes and quality of life. The global interventional radiology imaging market is projected to grow from USD 16.99 Billion in 2023 to USD 23.50 Billion by 2031, with a 6.7% CAGR from 2023 to 2031.
Interventional nephrology summits | Nephrology meetings | Nephrology conferences | Kidney conferences
Session 11: Kidney Organoids and Tissue Engineering
Kidney organoids, derived from stem cells, provide insights into kidney development, disease modeling, and drug testing. Tissue engineering, using cells, scaffolds, and bioactive molecules, aims to create functional kidney tissue for transplantation and research. Challenges include vascularization and immunogenicity. The organoids market is projected to reach $12.2 billion by 2030, with a 21.9% CAGR.
Tissue Engineering conferences | Regenerative medicine summits | Kidney meets | Renal care summits
Session 12: Pediatric Nephrology
Pediatric nephrology focuses on diagnosing and managing kidney-related conditions in children, covering congenital anomalies, glomerular disorders, hypertension, and kidney diseases. Treatment includes medication, dialysis, or transplantation. Pediatric nephrologists collaborate with specialists, providing specialized, long-term care tailored to young patients. The pediatric nephrology market is projected to grow from $23.2 billion in 2020 to $35.8 billion by 2027.
Pediatric nephrology summits | Pediatric nephrology conferences | Pediatric nephrology events | Nephrology conference
Session 13: Global Health and Kidney Disease
Global Health aims to enhance well-being worldwide. Kidney disease poses a major concern, with increasing prevalence. Challenges include limited access to care, especially in low-resource areas, and addressing risk factors like hypertension and diabetes. Strategies involve prevention, early detection, and ensuring equal treatment access. The market was valued at USD 96.72 billion in 2021, projected to reach USD 148.43 billion by 2029.
Healthcare summit | Kidney disease conferences | Nephrology conferences | Nephrology meets
Session 14: Diabetic Nephropathy
Diabetic nephropathy is a serious complication of diabetes that affects the kidneys. It is characterized by damage to the small blood vessels in the kidneys, leading to impaired kidney function over time.Global Diabetic Nephropathy Market size was valued at USD 1.9 billion in 2021 and is poised to grow from USD 2.01 billion in 2022 to USD 3.21 billion by 2030, growing at a CAGR of 6% in the forecast period (2023-2030).
Healthcare summit | Kidney disease conferences | Nephrology conferences | Nephrology meets
Session 15: Cardio-Renal Syndromes
Cardio-renal syndromes (CRS) represent a complex interplay between the heart and kidneys, where dysfunction in one organ can induce dysfunction in the other. Understanding CRS is crucial for managing patients with heart and kidney diseases, as these conditions often coexist and exacerbate each other.The overall CAGR for the CRS market is expected to be in the range of 6-7% from 2021 to 2025, reflecting strong demand and continuous advancements in medical technology and patient care.
Healthcare summit | Kidney disease conferences | Nephrology conferences | Nephrology meets

The Global Nephrology market was valued at USD 3.34 billion in 2023, accounted for USD 4.60 billion in 2025, and is expected to reach around USD 7.08 billion by 2033, expanding at a CAGR of 7.60% from 2025 to 2033.Factors such as increasing incidence of kidney failure, adaptation to unhealthy lifestyles, increasing prevalence of chronic nephrological diseases, increasing geriatric population, increasing demand for diagnostic tests, increasing excessive alcohol consumption, and increasing obesity are driving the growth of nephrological drugs.

Cases of COVID-19 are related to the kidneys, and 50% of hospitalized patients with COVID-19 have acute kidney disease. Advancements in technology in developing countries, increasing demand for targeted and immunotherapies, advances in diagnostics and renal therapy, increased research and development for drug improvement and new drug launches, as well as joint ventures and agreements between major market players are accelerating the growth of nephrology drugs. However, high treatment costs and ignorance about kidney diseases hinder the growth of the market. Conversely, government initiatives coupled with regulatory approval and affordable insurance offer lucrative opportunities for market expansion.

Global Nephrology Universities associated with the Nephrology 2026 conference:
• Harvard University, USA
• Johns Hopkins University, USA
• Technion - Israel Institute of Technology, Israel
• Paris Cité University, France
• University of Groningen, Netherlands
• University College London, United Kingdom
• Peking University, China
• University of Tokyo, Japan
• Autonomous University of Madrid, Spain
• Seoul National University, South Korea
• Medical University Innsbruck, Austria
• Shahid Beheshti University of Medical Sciences and Health Services, Iran
• The Chinese University of Hong Kong, Hong Kong
• Cairo University, Egypt
• Charles University, Czech Republic
• Istanbul University-CerrahpaÅŸa, Turkey
• King Abdulaziz University, Saudi Arabia
• State University of Rio de Janeiro, Brazil
• Martin Luther University Halle-Wittenberg, Germany
• University of Porto, Portugal
• University of Ljubljana, Slovenia
• University of the Republic, Uruguay

The nephrology market exhibits robust growth potential, propelled by factors like rising kidney-related ailments, COVID-19's impact, technological advancements, and increased R&D efforts.

The Young Research Forum at the Nephrology 2026 Conference is a platform dedicated to fostering the development and nurturing of the talent of young nephrologists and researchers. This forum aims to provide a unique space for young professionals to exchange ideas, showcase their research, and engage in meaningful discussions with peers and established experts in the field of nephrology. The content for this forum is carefully curated to address emerging trends, breakthroughs, and challenges in nephrology, with a focus on encouraging innovative thinking and collaboration among the next generation of researchers.
The content outlined for the Young Research Forum at the Nephrology 2026 Conference embodies the spirit of innovation and collaboration that is crucial for advancing the field of nephrology. By addressing a diverse range of topics, from cutting-edge treatment modalities to groundbreaking research methodologies, this forum aims to inspire and empower the next generation of nephrologists, ensuring a brighter future for kidney health worldwide.

We are pleased to announce the awards that will be presented at the Nephrology 2026 Conference. These awards aim to recognize outstanding contributions and achievements in the field of nephrology.

We encourage all eligible participants to consider applying for these prestigious accolades.
1. Lifetime Achievement Award
2. Young Scientist Award
3. Innovation in Technology Award
4. Excellence in Education and Outreach Award

These awards not only acknowledge the outstanding achievements of the researchers but also highlight the collaborative spirit and dedication that defines the Nephrology community.
Join us in celebrating the accomplishments at the Nephrology 2026, where we will showcase their work through presentations, discussions, and a special awards ceremony. Your presence will contribute to the vibrant exchange of ideas that drives our field forward.
We look forward to welcoming you to this year's Nephrology 2026, where we will celebrate excellence, innovation, and the pursuit of knowledge in nephrology.

Elevate your brand's presence and impact by collaborating or exhibiting at the Nephrology 2026 Conference. This premier event offers a unique platform to showcase your products, services, and innovations to a targeted audience of nephrology experts, researchers, and healthcare professionals. You can position your organization as a leader in the field with tailored sponsorship and exhibition packages. From top-tier Platinum Sponsorship to engaging Collaborative Sessions, there are opportunities for every level of involvement. Connect with decision-makers, unveil your latest offerings, and demonstrate your commitment to advancing nephrology.

For more information on how to get involved, don't hesitate to get in touch with the below details:
Natalie Wright
Conference Director | Nephrology 2026
E-mail: contact@meetingsint.com
Whatsapp: +44 7520604474

Secure your sponsorship or exhibition space today and make a lasting impact on the nephrology community.